Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole M Haynes

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Gene-engineered T cells as a superior adjuvant therapy for metastatic cancerMichael H Kershaw, Jacob T Jackson, Nicole M Haynes, et al.
The Journal of Clinical Investigation|March 5, 2013
Host immunity contributes to the anti-melanoma activity of BRAF inhibitorsDeborah A Knight, Shin Foong Ngiow, Ming Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2008
Death receptor 5 mediated-apoptosis contributes to cholestatic liver diseaseKazuyoshi Takeda, Yuko Kojima, Kenichi Ikejima, et al.
Cancer Research|March 3, 2017
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2<sup>+</sup> TumorsMikolaj Medon, Eva Vidacs, Stephin J Vervoort, et al.
Nature|October 2, 2009
Membrane-bound Fas ligand only is essential for Fas-induced apoptosisLorraine A O' Reilly, Lin Tai, Lily Lee, et al.
Cancer Research|January 14, 2017
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T CellsSherly Mardiana, Liza B John, Melissa A Henderson, et al.
The Journal of Clinical Investigation|November 16, 2013
Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formationMaya Kansara, Huei San Leong, Dan Mei Lin, et al.
Cancer Immunology Research|July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic CellsPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2008
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonistAilsa J Frew, Ralph K Lindemann, Ben P Martin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 12, 2018
A Functional Immune System Is Required for the Systemic Genotoxic Effects of Localized IrradiationPavel N Lobachevsky, Jessica Ventura, Lina Giannakandropoulou, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Gene-engineered T cells as a superior adjuvant therapy for metastatic cancerMichael H Kershaw, Jacob T Jackson, Nicole M Haynes, et al.
The Journal of Clinical Investigation|March 5, 2013
Host immunity contributes to the anti-melanoma activity of BRAF inhibitorsDeborah A Knight, Shin Foong Ngiow, Ming Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2008
Death receptor 5 mediated-apoptosis contributes to cholestatic liver diseaseKazuyoshi Takeda, Yuko Kojima, Kenichi Ikejima, et al.
Cancer Research|March 3, 2017
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2<sup>+</sup> TumorsMikolaj Medon, Eva Vidacs, Stephin J Vervoort, et al.
Nature|October 2, 2009
Membrane-bound Fas ligand only is essential for Fas-induced apoptosisLorraine A O' Reilly, Lin Tai, Lily Lee, et al.
Cancer Research|January 14, 2017
A Multifunctional Role for Adjuvant Anti-4-1BB Therapy in Augmenting Antitumor Response by Chimeric Antigen Receptor T CellsSherly Mardiana, Liza B John, Melissa A Henderson, et al.
The Journal of Clinical Investigation|November 16, 2013
Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formationMaya Kansara, Huei San Leong, Dan Mei Lin, et al.
Cancer Immunology Research|July 19, 2018
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4<sup>+</sup>Foxp3<sup>-</sup> Cell-Mediated Modulation of CD103<sup>+</sup> Dendritic CellsPaul A Beavis, Melissa A Henderson, Lauren Giuffrida, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2008
Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonistAilsa J Frew, Ralph K Lindemann, Ben P Martin, et al.
International Journal of Radiation Oncology, Biology, Physics|December 12, 2018
A Functional Immune System Is Required for the Systemic Genotoxic Effects of Localized IrradiationPavel N Lobachevsky, Jessica Ventura, Lina Giannakandropoulou, et al.
Pageof 5